by MM360 Staff | Dec 25, 2025 | Uncategorized
Source: CURE articles Post Content Read More
by MM360 Staff | Dec 25, 2025 | Uncategorized
Source: CURE articles Post Content Read More
by Shahzad Raza, MD; Holly Vernyi | Dec 24, 2025 | Uncategorized
In this interview Shahzad Raza, MD, discusses a study on the treatment of patients with extramedullary myeloma, as presented at ASH 2025.“I found this to be a really exciting study. I don’t think we can do this type of study in the future easily, because these...
by Holly Vernyi | Dec 24, 2025 | Uncategorized
In this interview Ira Zackon, MD, highlights data on bispecific antibody use in patients with multiple myeloma in the community setting as presented at ASH 2025.Zackon noted that the retrospective observational study included representation of Black Americans and...
by Mark Leiser | Dec 15, 2025 | Uncategorized
ORLANDO — An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited activity among patients with advanced multiple myeloma, according to findings presented at ASH Annual Meeting and Exposition.The first four patients treated...
by MM360 Staff | Dec 10, 2025 | Uncategorized
Source: CURE articles Post Content Read More
